Drugs / DWJ1506
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04772443 | Feb 2021 → Dec 2022 | hyperlipidemia | Daewoong Pharmaceutical Co. LTD. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWJ1506 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04772443 ↗ |